Avid Bioservices Inc (CDMO)

[bimerkjaere]

A little history from my side - the way i first came on to bavi was working at BMS. I was part of a R&D Strat group and I identified bavi and Cotara from a list of 100 most promising biotech molecules in clinical development. I FWD bavi onto our transaction group as I noticed they were both unlicensed. Never heard anything from them (at the time, pphm had a $100M MC). Although they are arguably the leader in immuno-oncology, I can't see them pulling the trigger on bavi now. BMS has a history of a somewhat conservative licensing strategy, and the BP that will take on bavi will need to acknowledge the major risk associated with this molecule.

Disclosure: I do not currently work for BMS anymore, although still in the pharma business.